(Q33999656)

PubMed publication ID

16988050

30 July 2017

title

Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

experimental autoimmune encephalomyelitis

11 May 2020

main subject

0 references

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

Samia Khoury

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

6

Tanuja Chitnis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

author name string

Shinjiro Kaneko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

Jing Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

Marie Kaneko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

Joanna M Hurrell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

Zhigang He

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

language of work or name

English

0 references

publication date

1 September 2006

1 reference

PubMed publication ID

16988050

30 July 2017

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

page(s)

9794-9804

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

Poly(ADP-ribose) polymerase-1 in the nervous system

11 May 2020

cites work

1 reference

12 December 2020

Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice

1 reference

12 December 2020

Multiple sclerosis: a two-stage disease

1 reference

12 December 2020

Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.

1 reference

12 December 2020

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Axonal self-destruction and neurodegeneration

1 reference

12 December 2020

Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury

1 reference

12 December 2020

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

1 reference

12 December 2020

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

1 reference

12 December 2020

Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain

1 reference

12 December 2020

Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway

1 reference

12 December 2020

Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration

1 reference

12 December 2020

Nicotinamide Offers Multiple Protective Mechanisms in Stroke as a Precursor for NAD<sup>+</sup>, as a PARP Inhibitor and by Partial Restoration of Mitochondrial Function

1 reference

12 December 2020

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease

1 reference

12 December 2020

The new life of a centenarian: signalling functions of NAD(P).

1 reference

12 December 2020

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

1 reference

12 December 2020

Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration

1 reference

12 December 2020

Sodium channel blockers and axonal protection in neuroinflammatory disease

1 reference

12 December 2020

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

12 December 2020

General mechanisms of axonal damage and its prevention

1 reference

12 December 2020

Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis

1 reference

12 December 2020

Natalizumab and progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Axon retraction and degeneration in development and disease

1 reference

12 December 2020

A local mechanism mediates NAD-dependent protection of axon degeneration

1 reference

12 December 2020

Axon degeneration mechanisms: commonality amid diversity

1 reference

12 December 2020

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

1 reference

12 December 2020

Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Effect of Huntington’s and Alzheimer’s Diseases on the Transport of Nicotinic Acid or Nicotinamide Across the Human Blood-Brain Barrier

1 reference

12 December 2020

Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

1 reference

12 December 2020

10.1523/JNEUROSCI.2116-06.2006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674451&resulttype=core&format=json

11 May 2020

PubMed publication ID

16988050

1 reference